查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1859077

注射剂市场报告：趋势、预测和竞争分析（至2031年）

Parenteral Drug Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

由于医院和医疗中心的市场机会，全球注射剂市场前景看好。预计2025年至2031年，全球注射剂市场将以4.1%的复合年增长率成长。推动该市场成长的关键因素包括生物製剂需求的成长、慢性病盛行率的上升以及注射使用率的提高。

  • 根据 Lucintel 的预测，LVP 药物在预测期内有望实现高速成长。
  • 从应用领域来看，医疗中心预计将实现高速成长。
  • 从区域来看，预计亚太地区在预测期内将达到最高成长。

注射剂药物市场的新趋势

在科学突破、病患需求变化和药物传递技术进步的推动下，注射剂市场正经历着深刻的变革时期。这些新兴趋势正在塑造药品生产和患者照护的未来。

  • 生技药品和生物相似药的崛起：单株抗体、基因疗法和细胞疗法等生物製药的研发和核准不断增长，已成为一大趋势。由于这些大分子药物通常需要肠外给药，其成长直接推动了对注射剂型和先进给药系统的需求。
  • 以患者为中心的给药装置：目前，开发易于使用的肠外给药装置以供患者在家中自行给药已成为日益增长的趋势。预填充式注射器、自动注射器和穿戴式註射器等创新技术正在提高患者的用药依从性，提升用药便利性，并减轻医疗机构的负担，尤其是在慢性病治疗方面。
  • 长效注射剂：市场对长效注射剂的关注度日益提高，这类药物可减少给药频率，提高病患依从性。长效注射剂在治疗思觉失调症、糖尿病和爱滋病等慢性疾病方面尤其有益，因为它们能够缓释性释放药物，并增强疗效。
  • 无菌生产技术的进步：随着生物製药的复杂性不断增加以及对高效价化合物的需求，无菌加工和生产技术的进步至关重要，包括采用隔离器技术、机器人填充生产线和严格的品管，以确保产品的安全性和完整性。
  • 个人化和标靶治疗医疗：个人化医疗的兴起，即根据个别患者的具体情况量身定制治疗方案，通常涉及透过肠外途径给药，使用高度特异性的药物。这一趋势推动了对小批量生产能力和标靶治疗专用给药系统的需求。

这些趋势正在显着地重塑肠外给药市场，加速开发复杂的高价值疗法，透过创新的给药方式提高患者的便利性，改善治疗依从性，并促进无菌生产过程的进步。

注射剂药物市场的最新趋势

受全球慢性病负担日益加重和药物科学进步的推动，注射剂市场正经历强劲成长和持续创新。这些发展正在提高药物疗效、患者用药便利性和整体医疗保健服务水准。

  • 生物製药研发加速：另一个重大进展是生物製药（包括单株抗体和先进疗法）的研究、开发和核准的快速成长。这些复杂的分子主要需要肠外给药，直接推动了对专用注射剂和先进给药方案的需求。
  • 病患自我给药装置：专为家庭使用而设计的便捷型肠外给药装置正变得越来越受欢迎。预填充式注射器、自动注射器和穿戴式註射器正变得越来越普遍，使患者能够轻鬆地自我给药，从而提高治疗依从性并降低医疗保健成本。
  • 无菌生产技术的进步：近期的趋势凸显了无菌生产能力的持续改进，包括采用隔离器技术和机器人填充生产线，这为注射药物提供了更高水平的无菌性和品质保证，这对敏感生技药品和高效价化合物至关重要。
  • 聚焦长效製剂：长效注射药物的研发是近年来的一大趋势。这些创新製剂可减少注射频率，提高患者依从性，延长慢性病治疗的疗效，进而对患者预后产生正面影响。
  • 受託製造厂商的扩张：合约生产机构（CMO）正在大幅扩展其註射剂生产能力和专业技术。这项发展使得製药公司能够将复杂的无菌填充和包装工序外包，加速药物研发和商业化，尤其对中小型生技公司更是如此。

这些趋势对肠外给药市场产生了重大影响，扩大了可治疗疾病的范围，提高了患者的用药便利性，改善了产品质量，提高了用药依从性，并简化了药物开发和生产流程。

目录

第一章执行摘要

第二章 市场概览

  • 背景和分类
  • 供应链

第三章：市场趋势与预测分析

  • 产业驱动因素与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

第四章 全球注射剂市场（按类型划分）

  • 概述
  • 吸引力分析：按类型
  • 大剂量药物：趋势与预测（2019-2031）
  • SVP药物：趋势与预测（2019-2031）

5. 全球注射剂市场（按应用划分）

  • 概述
  • 吸引力分析：依目的
  • 医院：趋势与预测（2019-2031）
  • 医疗中心：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031 年）

第六章 区域分析

  • 概述
  • 全球注射剂市场（按地区划分）

7. 北美注射剂市场

  • 概述
  • 北美注射市场按类型划分
  • 北美注射剂市场按应用领域划分
  • 美国肠外药物市场
  • 墨西哥注射剂市场
  • 加拿大肠外药物市场

8. 欧洲注射药物市场

  • 概述
  • 欧洲注射剂市场按类型划分
  • 欧洲注射剂市场按应用领域划分
  • 德国注射剂市场
  • 法国注射剂市场
  • 西班牙肠外药物市场
  • 义大利肠外药物市场
  • 英国肠外营养市场

9. 亚太地区注射剂市场

  • 概述
  • 亚太地区注射剂市场（按类型划分）
  • 亚太地区注射剂市场按应用领域划分
  • 日本的注射用药物市场
  • 印度肠外药品市场
  • 中国的注射剂药物市场
  • 韩国注射剂市场
  • 印尼注射剂市场

10. 其他地区（ROW）肠外给药市场

  • 概述
  • 按类型分類的ROW注射市场
  • 按应用领域分類的 ROW 注射剂市场
  • 中东肠外药物市场
  • 南美洲注射市场
  • 非洲肠外药物市场

第十一章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市占率分析

第十二章：机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 发展机会：透过申请
  • 全球注射剂药物市场的新趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 企业合併、协议、合作关係和合资企业

第十三章：价值链中主要企业的概况

  • 竞争分析
  • Ostuka Pharmaceutical
  • Teva Pharmaceutical Industries
  • Kelun Pharma
  • Cook Pharmica
  • Patheon
  • BAG Healthcare
  • Beximco Pharma
  • Baxter Healthcare Corporation
  • B. Braun
  • Fresenius

第十四章附录

  • 图表清单
  • 表格列表
  • 分析方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于 Lucintel
  • 询问

The future of the global parenteral drug market looks promising with opportunities in the hospital and medical center markets. The global parenteral drug market is expected to grow with a CAGR of 4.1% from 2025 to 2031. The major drivers for this market are the increasing demand for biologic therapies, the rising prevalence of chronic diseases, and the growing adoption of injectable drugs.

  • Lucintel forecasts that, within the type category, LVP drug is expected to witness higher growth over the forecast period.
  • Within the application category, medical center is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Parenteral Drug Market

The parenteral drug market is undergoing significant transformation, driven by scientific breakthroughs, evolving patient needs, and advancements in drug delivery technologies. These emerging trends are shaping the future of pharmaceutical manufacturing and patient care.

  • Rise of Biologics and Biosimilars: The increasing development and approval of biologic drugs, including monoclonal antibodies, gene therapies, and cell therapies, are a major trend. As these large-molecule drugs often require parenteral administration, their growth directly fuels the demand for injectable formulations and advanced delivery systems.
  • Patient-Centric Delivery Devices: There's a strong trend towards developing user-friendly parenteral drug delivery devices for self-administration at home. Innovations like prefilled syringes, auto-injectors, and wearable injectors are improving patient adherence, convenience, and reducing the burden on healthcare facilities, especially for chronic conditions.
  • Long-Acting Injectables: The market is seeing a growing emphasis on long-acting injectable formulations that reduce dosing frequency and improve patient compliance. LAIs are particularly beneficial for managing chronic diseases like schizophrenia, diabetes, and HIV, offering sustained drug release and enhancing therapeutic outcomes.
  • Sterile Manufacturing Advancements: With the increasing complexity of biologic drugs and the need for high-potency compounds, advancements in aseptic processing and sterile manufacturing technologies are critical. This includes the adoption of isolator technology, robotic fill-finish lines, and stringent quality control to ensure product safety and integrity.
  • Personalized Medicine & Targeted Therapies: The shift towards personalized medicine, where treatments are tailored to individual patient profiles, often involves parenteral administration of highly specific drugs. This trend drives demand for small-batch manufacturing capabilities and specialized delivery systems for targeted therapies.

These trends are significantly reshaping the parenteral drug market by fostering the development of complex and high-value therapeutics, enhancing patient convenience through innovative delivery methods, improving treatment adherence, and driving advancements in sterile manufacturing processes.

Recent Developments in the Parenteral Drug Market

The parenteral drug market is experiencing robust growth and continuous innovation, driven by the increasing global burden of chronic diseases and advancements in pharmaceutical science. These developments are enhancing drug efficacy, patient convenience, and overall healthcare delivery.

  • Increased Biologic Drug Development: A significant development is the surge in research, development, and approval of biologic drugs, including monoclonal antibodies and advanced therapies. These complex molecules primarily require parenteral administration, directly fueling demand for specialized injectable formulations and sophisticated delivery solutions.
  • Patient Self-Administration Devices: There's a notable development in the proliferation of user-friendly parenteral devices designed for home use. Prefilled syringes, auto-injectors, and wearable injectors are becoming more common, empowering patients to self-administer medications conveniently, thereby improving treatment adherence and reducing healthcare costs.
  • Advancements in Sterile Manufacturing: Recent developments highlight continuous improvements in sterile manufacturing capabilities, including the adoption of isolator technologies and robotic fill-finish lines. This ensures higher levels of sterility and quality for injectable drugs, crucial for sensitive biologics and high-potency compounds.
  • Focus on Long-Acting Formulations: The development of long-acting injectable formulations is a key recent trend. These innovative formulations reduce the frequency of injections, offering improved patient compliance and sustained therapeutic effects for chronic disease management, impacting patient outcomes positively.
  • Expansion of Contract Manufacturing Organizations: CMOs are significantly expanding their parenteral manufacturing capacities and expertise. This development allows pharmaceutical companies to outsource complex sterile fill-finish operations, accelerating drug development and commercialization, especially for small and mid-sized biotech firms.

These developments are profoundly impacting the parenteral drug market by expanding the range of treatable conditions, enhancing patient access and convenience, ensuring higher product quality, improving adherence to medication regimens, and streamlining the drug development and manufacturing processes.

Strategic Growth Opportunities in the Parenteral Drug Market

The parenteral drug market offers substantial strategic growth opportunities across various applications, driven by evolving medical needs, technological advancements, and a focus on patient convenience. Capitalizing on these opportunities is key for market players.

  • Oncology and Autoimmune Diseases: The high prevalence of cancer and autoimmune disorders, coupled with the increasing development of targeted biologic therapies, presents significant growth. Parenteral administration is crucial for these high-potency drugs, making this a prime area for specialized injectable formulations and delivery devices.
  • Chronic Disease Management: The rising global burden of chronic conditions like diabetes, cardiovascular diseases, and neurological disorders offers a major opportunity. Developing long-acting injectables and user-friendly self-administration devices for these conditions can improve patient adherence and quality of life, driving market expansion.
  • Vaccines and Gene Therapies: The ongoing development of new vaccines and the emergence of gene therapies represent a high-growth segment. These often require precise parenteral delivery, creating opportunities for advanced prefilled syringes, multi-dose vials, and novel delivery platforms to ensure effective administration.
  • Home Healthcare and Self-Administration: The shift towards home-based care for many conditions creates a strong opportunity for parenteral drugs designed for patient self-administration. Investing in ergonomic auto-injectors, wearable pumps, and supportive digital health solutions can capture this expanding market segment.
  • Biosimilar Development and Manufacturing: As patents for various biologics expire, the biosimilar market is booming, often requiring parenteral administration. Focusing on efficient and cost-effective manufacturing of biosimilar injectables, including fill-finish services, presents a significant opportunity for both pharmaceutical companies and CMOs.

These strategic growth opportunities are significantly impacting the parenteral drug market by fostering innovation in high-demand therapeutic areas, enhancing patient accessibility and adherence through convenient delivery systems, and driving the development of cost-effective alternatives in critical drug categories.

Parenteral Drug Market Driver and Challenges

The parenteral drug market is influenced by a dynamic interplay of various technological, economic, and regulatory factors. These elements serve as both significant drivers propelling market expansion and crucial challenges that necessitate strategic responses from industry participants.

The factors responsible for driving the parenteral drug market include:

1. Increasing Chronic Disease Prevalence: The global rise in chronic diseases such as cancer, diabetes, and autoimmune disorders significantly drives the parenteral drug market. These conditions often require long-term treatment with high-potency drugs best delivered via injection, ensuring effective and reliable therapeutic outcomes.

2. Growth of Biologics and Biosimilars: The escalating development and market penetration of complex biologic drugs (e.g., monoclonal antibodies, cell and gene therapies) and their biosimilar counterparts is a major driver. Due to their molecular structure, these therapies almost exclusively require parenteral administration, fueling demand for injectables.

3. Technological Advancements in Delivery Systems: Innovations in parenteral drug delivery, including prefilled syringes, auto-injectors, and wearable injectors, enhance patient convenience, safety, and adherence. These advancements facilitate self-administration, reduce healthcare burden, and significantly expand the market.

4. Rising Geriatric Population: The global increase in the elderly population contributes to market growth, as older individuals are more susceptible to chronic diseases requiring parenteral treatments. Additionally, parenteral administration can be easier for patients with swallowing difficulties or impaired gastrointestinal absorption.

5. Increased Focus on Personalized Medicine: The shift towards personalized and targeted therapies often involves highly potent drugs delivered parenterally to specific sites or patient subsets. This trend drives demand for customized injectable formulations and precision delivery systems, enhancing treatment efficacy.

Challenges in the parenteral drug market are:

1. High Manufacturing Costs: The production of parenteral drugs demands stringent sterile environments, specialized equipment, and complex quality control processes. These requirements lead to significantly higher manufacturing costs compared to oral solid dosage forms, impacting profitability and product pricing.

2. Stringent Regulatory Requirements: Parenteral drugs are subject to very strict regulatory oversight due to their direct entry into the bloodstream, necessitating rigorous testing for sterility, pyrogens, and particulate matter. Navigating diverse and evolving global regulations poses a significant challenge for manufacturers, affecting approval timelines.

3. Risk of Needlestick Injuries and Patient Compliance: Despite advancements, the use of needles for parenteral administration carries risks like needlestick injuries and can cause fear or discomfort, potentially leading to poor patient compliance. This challenge necessitates continuous innovation in safer and more patient-friendly delivery devices.

These drivers and challenges on the parenteral drug market is one of sustained growth, fueled by medical necessity and technological innovation. However, addressing the inherent complexities of manufacturing, stringent regulatory demands, and patient-related challenges will be crucial for broader accessibility and continued market expansion.

List of Parenteral Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies parenteral drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the parenteral drug companies profiled in this report include-

  • Ostuka Pharmaceutical
  • Teva Pharmaceutical Industries
  • Kelun Pharma
  • Cook Pharmica
  • Patheon
  • BAG Healthcare
  • Beximco Pharma
  • Baxter Healthcare Corporation
  • B. Braun
  • Fresenius

Parenteral Drug Market by Segment

The study includes a forecast for the global parenteral drug market by type, application, and region.

Parenteral Drug Market by Type [Value from 2019 to 2031]:

  • LVP Drug
  • SVP Drug

Parenteral Drug Market by Application [Value from 2019 to 2031]:

  • Hospital
  • Medical Centers
  • Others

Parenteral Drug Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Parenteral Drug Market

The parenteral drug market is experiencing dynamic growth, driven by the increasing prevalence of chronic diseases, advancements in biotechnology, and the rising demand for targeted therapies. This market, encompassing injectable drugs, plays a critical role in delivering high-potency and complex molecules, and is evolving rapidly with innovations in drug delivery systems and manufacturing processes globally.

  • United States: The U.S. parenteral drug market is expanding significantly due to the increasing demand for biologics and targeted therapies, particularly for chronic diseases like cancer and diabetes. There's a notable shift towards home healthcare, driven by the development of patient-friendly self-administration devices like prefilled syringes and auto-injectors, enhancing patient convenience and reducing hospital visits.
  • China: China parenteral drug market is witnessing robust growth, fueled by rising healthcare expenditure, a large aging population, and increasing prevalence of chronic diseases. Recent developments include significant investments in local manufacturing capabilities for injectable drugs, with a focus on improving new drug approval timelines and enhancing overall pharmaceutical presence.
  • Germany: Germany pharmaceutical market, a key player in Europe, sees parenteral delivery rising steadily. Driven by strong biopharmaceutical investments, an aging population, and a focus on specialized therapies, there's increased capacity for complex biologics. Recent acquisitions and expansions in sterile manufacturing facilities further bolster its position in parenteral drug production.
  • India: India parenteral drug market is experiencing growth driven by increased healthcare access, rising chronic disease burden, and a growing pharmaceutical manufacturing sector. Indian companies are actively launching new product lines and expanding manufacturing capabilities for injectable drugs, focusing on both domestic demand and export opportunities, indicating a dynamic market.
  • Japan: Japan parenteral drug market is influenced by its aging population and a focus on innovative therapies, including gene therapies and antibody-drug conjugates, which often require parenteral administration. Recent regulatory reforms aim to streamline drug development and accelerate market access for novel medicines, indicating a push towards high-value injectable treatments.

Features of the Global Parenteral Drug Market

  • Market Size Estimates: Parenteral drug market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Parenteral drug market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Parenteral drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, applications, and regions for the parenteral drug market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the parenteral drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the parenteral drug market by type (LVP drug and SVP drug), application (hospital, medical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Parenteral Drug Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 LVP Drug: Trends and Forecast (2019-2031)
  • 4.4 SVP Drug: Trends and Forecast (2019-2031)

5. Global Parenteral Drug Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospitals: Trends and Forecast (2019-2031)
  • 5.4 Medical Centers: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Parenteral Drug Market by Region

7. North American Parenteral Drug Market

  • 7.1 Overview
  • 7.2 North American Parenteral Drug Market by Type
  • 7.3 North American Parenteral Drug Market by Application
  • 7.4 United States Parenteral Drug Market
  • 7.5 Mexican Parenteral Drug Market
  • 7.6 Canadian Parenteral Drug Market

8. European Parenteral Drug Market

  • 8.1 Overview
  • 8.2 European Parenteral Drug Market by Type
  • 8.3 European Parenteral Drug Market by Application
  • 8.4 German Parenteral Drug Market
  • 8.5 French Parenteral Drug Market
  • 8.6 Spanish Parenteral Drug Market
  • 8.7 Italian Parenteral Drug Market
  • 8.8 United Kingdom Parenteral Drug Market

9. APAC Parenteral Drug Market

  • 9.1 Overview
  • 9.2 APAC Parenteral Drug Market by Type
  • 9.3 APAC Parenteral Drug Market by Application
  • 9.4 Japanese Parenteral Drug Market
  • 9.5 Indian Parenteral Drug Market
  • 9.6 Chinese Parenteral Drug Market
  • 9.7 South Korean Parenteral Drug Market
  • 9.8 Indonesian Parenteral Drug Market

10. ROW Parenteral Drug Market

  • 10.1 Overview
  • 10.2 ROW Parenteral Drug Market by Type
  • 10.3 ROW Parenteral Drug Market by Application
  • 10.4 Middle Eastern Parenteral Drug Market
  • 10.5 South American Parenteral Drug Market
  • 10.6 African Parenteral Drug Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Parenteral Drug Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Ostuka Pharmaceutical
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Teva Pharmaceutical Industries
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Kelun Pharma
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Cook Pharmica
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Patheon
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 BAG Healthcare
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Beximco Pharma
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Baxter Healthcare Corporation
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 B. Braun
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Fresenius
    • Company Overview
    • Parenteral Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Parenteral Drug Market
  • Figure 2.1: Usage of Parenteral Drug Market
  • Figure 2.2: Classification of the Global Parenteral Drug Market
  • Figure 2.3: Supply Chain of the Global Parenteral Drug Market
  • Figure 3.1: Driver and Challenges of the Parenteral Drug Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Parenteral Drug Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Parenteral Drug Market ($B) by Type
  • Figure 4.3: Forecast for the Global Parenteral Drug Market ($B) by Type
  • Figure 4.4: Trends and Forecast for LVP Drug in the Global Parenteral Drug Market (2019-2031)
  • Figure 4.5: Trends and Forecast for SVP Drug in the Global Parenteral Drug Market (2019-2031)
  • Figure 5.1: Global Parenteral Drug Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Parenteral Drug Market ($B) by Application
  • Figure 5.3: Forecast for the Global Parenteral Drug Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospitals in the Global Parenteral Drug Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Medical Centers in the Global Parenteral Drug Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global Parenteral Drug Market (2019-2031)
  • Figure 6.1: Trends of the Global Parenteral Drug Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Parenteral Drug Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Parenteral Drug Market by Type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Parenteral Drug Market ($B) by Type (2019-2024)
  • Figure 7.3: Forecast for the North American Parenteral Drug Market ($B) by Type (2025-2031)
  • Figure 7.4: North American Parenteral Drug Market by Application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Parenteral Drug Market ($B) by Application (2019-2024)
  • Figure 7.6: Forecast for the North American Parenteral Drug Market ($B) by Application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Parenteral Drug Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Parenteral Drug Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Parenteral Drug Market ($B) (2019-2031)
  • Figure 8.1: European Parenteral Drug Market by Type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Parenteral Drug Market ($B) by Type (2019-2024)
  • Figure 8.3: Forecast for the European Parenteral Drug Market ($B) by Type (2025-2031)
  • Figure 8.4: European Parenteral Drug Market by Application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Parenteral Drug Market ($B) by Application (2019-2024)
  • Figure 8.6: Forecast for the European Parenteral Drug Market ($B) by Application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Parenteral Drug Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Parenteral Drug Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Parenteral Drug Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Parenteral Drug Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Parenteral Drug Market ($B) (2019-2031)
  • Figure 9.1: APAC Parenteral Drug Market by Type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Parenteral Drug Market ($B) by Type (2019-2024)
  • Figure 9.3: Forecast for the APAC Parenteral Drug Market ($B) by Type (2025-2031)
  • Figure 9.4: APAC Parenteral Drug Market by Application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Parenteral Drug Market ($B) by Application (2019-2024)
  • Figure 9.6: Forecast for the APAC Parenteral Drug Market ($B) by Application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Parenteral Drug Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Parenteral Drug Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Parenteral Drug Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Parenteral Drug Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Parenteral Drug Market ($B) (2019-2031)
  • Figure 10.1: ROW Parenteral Drug Market by Type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Parenteral Drug Market ($B) by Type (2019-2024)
  • Figure 10.3: Forecast for the ROW Parenteral Drug Market ($B) by Type (2025-2031)
  • Figure 10.4: ROW Parenteral Drug Market by Application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Parenteral Drug Market ($B) by Application (2019-2024)
  • Figure 10.6: Forecast for the ROW Parenteral Drug Market ($B) by Application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Parenteral Drug Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Parenteral Drug Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Parenteral Drug Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Parenteral Drug Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Parenteral Drug Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Parenteral Drug Market by Type
  • Figure 12.2: Growth Opportunities for the Global Parenteral Drug Market by Application
  • Figure 12.3: Growth Opportunities for the Global Parenteral Drug Market by Region
  • Figure 12.4: Emerging Trends in the Global Parenteral Drug Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Parenteral Drug Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Parenteral Drug Market by Region
  • Table 1.3: Global Parenteral Drug Market Parameters and Attributes
  • Table 3.1: Trends of the Global Parenteral Drug Market (2019-2024)
  • Table 3.2: Forecast for the Global Parenteral Drug Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Parenteral Drug Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Parenteral Drug Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Parenteral Drug Market (2025-2031)
  • Table 4.4: Trends of LVP Drug in the Global Parenteral Drug Market (2019-2024)
  • Table 4.5: Forecast for LVP Drug in the Global Parenteral Drug Market (2025-2031)
  • Table 4.6: Trends of SVP Drug in the Global Parenteral Drug Market (2019-2024)
  • Table 4.7: Forecast for SVP Drug in the Global Parenteral Drug Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Parenteral Drug Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Parenteral Drug Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Parenteral Drug Market (2025-2031)
  • Table 5.4: Trends of Hospitals in the Global Parenteral Drug Market (2019-2024)
  • Table 5.5: Forecast for Hospitals in the Global Parenteral Drug Market (2025-2031)
  • Table 5.6: Trends of Medical Centers in the Global Parenteral Drug Market (2019-2024)
  • Table 5.7: Forecast for Medical Centers in the Global Parenteral Drug Market (2025-2031)
  • Table 5.8: Trends of Others in the Global Parenteral Drug Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global Parenteral Drug Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Parenteral Drug Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Parenteral Drug Market (2025-2031)
  • Table 7.1: Trends of the North American Parenteral Drug Market (2019-2024)
  • Table 7.2: Forecast for the North American Parenteral Drug Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Parenteral Drug Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Parenteral Drug Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Parenteral Drug Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Parenteral Drug Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Parenteral Drug Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Parenteral Drug Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Parenteral Drug Market (2019-2031)
  • Table 8.1: Trends of the European Parenteral Drug Market (2019-2024)
  • Table 8.2: Forecast for the European Parenteral Drug Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Parenteral Drug Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Parenteral Drug Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Parenteral Drug Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Parenteral Drug Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Parenteral Drug Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Parenteral Drug Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Parenteral Drug Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Parenteral Drug Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Parenteral Drug Market (2019-2031)
  • Table 9.1: Trends of the APAC Parenteral Drug Market (2019-2024)
  • Table 9.2: Forecast for the APAC Parenteral Drug Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Parenteral Drug Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Parenteral Drug Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Parenteral Drug Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Parenteral Drug Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Parenteral Drug Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Parenteral Drug Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Parenteral Drug Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Parenteral Drug Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Parenteral Drug Market (2019-2031)
  • Table 10.1: Trends of the ROW Parenteral Drug Market (2019-2024)
  • Table 10.2: Forecast for the ROW Parenteral Drug Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Parenteral Drug Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Parenteral Drug Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Parenteral Drug Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Parenteral Drug Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Parenteral Drug Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Parenteral Drug Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Parenteral Drug Market (2019-2031)
  • Table 11.1: Product Mapping of Parenteral Drug Suppliers Based on Segments
  • Table 11.2: Operational Integration of Parenteral Drug Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Parenteral Drug Revenue
  • Table 12.1: New Product Launches by Major Parenteral Drug Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Parenteral Drug Market